^
    Back
    Association details:
    Biomarker:NTRK1-KHDRBS1 fusion
    Cancer:Sarcoma
    Drug:Xalkori (crizotinib) (ALK inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: C4 – Case Studies
    Source:
    World J Surg Oncol
    Title:

    Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment

    Published date:
    04/30/2021
    Excerpt:
    ...sarcoma carrying a neurotrophic tyrosine receptor kinase NTRK1-KHDRBS1 gene fusion that was diagnosed and treated at multiple hospitals...The patient achieved a long-term survival without tumor relapse after treatment with crizotinib.
    DOI:
    10.1186/s12957-021-02237-y